LGCs Clinical Diagnostics unit employing AccuPlex technology to develop quality control solutions in response to the coronavirus global health emergency

LGC’s Clinical Diagnostics unit employing AccuPlex™ technology to develop quality control solutions in response to the coronavirus global health emergency

LGC’s SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostic manufacturers and clinical laboratories, is announcing the development of molecular reference materials for coronavirus utilizing their proprietary AccuPlex™ recombinant technology. The control material is being produced in collaboration with several diagnostic manufacturers to support development, evaluation, and validation of molecular test methods directed to 2019-nCoV....

More From BioPortfolio on "LGC’s Clinical Diagnostics unit employing AccuPlex™ technology to develop quality control solutions in response to the coronavirus global health emergency"